cefixime has been researched along with Erythema Multiforme in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaouak, A | 1 |
| Daldoul, M | 1 |
| Chamli, A | 1 |
| Frioui, R | 1 |
| Khanchel, F | 1 |
| Brahim, EB | 1 |
| Fenniche, S | 1 |
| Hammami, H | 1 |
1 other study available for cefixime and Erythema Multiforme
| Article | Year |
|---|---|
Cefixime-induced bullous erythema multiforme major.
Topics: Cefixime; Erythema Multiforme; Humans | 2022 |